查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762469

全球核酸擴增檢測市場：市場規模、佔有率、趨勢、產業分析（依類型、應用、最終用途和地區）、未來預測（2025-2034）

Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到2034年，全球核酸擴增檢測市場規模將達到 288.6億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

核酸擴增檢測（NAAT）是一類強大的分子技術，目的是精確定位生物樣本中的特定遺傳物質，包括 DNA 和 RNA。這些檢測的基本原理是能夠將即使是微量的目標核酸擴增到可偵測的水準。這種擴增對於實現早期準確診斷所需的高靈敏度非常重要，尤其是在處理低濃度病原體和識別可能被忽略的細微遺傳變異時。 NAAT 的精準性和靈敏度使其成為現代診斷的基石，並在各個醫學學科的臨床決策中發揮關鍵作用。

傳染病的威脅始終存在，包括新病原體的出現和現有病原體的複發，這使得廣泛採用 NAAT 等高靈敏度診斷工具來有效控制和遏制疾病成為必要。此外，遺傳性疾病的日益普及以及分子診斷在腫瘤學中的應用日益廣泛，是 NAAT 市場需求趨勢的關鍵驅動因素。分子技術的不斷發展以及更快、更易用、更經濟高效的NAAT 平台的開發，拓寬 NAAT 的範圍和可及性，進一步促進這些重要診斷檢測方法的發展。

核酸擴增檢測市場：分析概論

依類型，聚合酶鍊式反應（PCR）檢測憑藉其高特異性、高靈敏度以及在各種診斷領域的廣泛適用性，在2024年佔據全球市場的最大佔有率。由於對快速即時檢測解決方案的需求不斷成長，恆溫核酸擴增技術（INAAT）檢測預計將在預測期內呈現最高成長率。

依應用，傳染病檢測領域預計將在2024年佔據最大佔有率，這得益於 NAAT 在診斷和監測各種傳染源方面的廣泛應用。由於分子診斷在癌症管理和個人化醫療方法的應用日益廣泛，腫瘤檢測預計將成為成長最快的應用領域。

根據最終用途，預計中央和參考實驗室將在2023年佔據核酸擴增檢測市場的最大佔有率。由於醫院日益整合先進的分子診斷技術，以加速和改善病患護理，醫院市場預計將呈現最高的成長率。

根據地區，北美將在2024年佔據最大的市場佔有率。預計亞太地區的核酸擴增檢測市場將在預測期內達到最高成長率。

活躍於該市場的主要公司包括F. Hoffmann-La Roche AG、Abbott Laboratories、Thermo Fisher Scientific Inc.、QIAGEN N.V.、bioMerieux S.A.、Becton, Dickinson and Company（BD）、Siemens Healthineers AG、Danaher Corporation（Cepheid）、Hologic, Inc.、Agilent Technologies, Inc.、Illumina, Inc.。

目錄

第1章 簡介

第2章 執行摘要

第3章 分析方法

第4章 全球核酸擴增檢測市場洞察

  • 市場概況
  • 核酸擴增檢測市場動態
    • 驅動因素與機會
      • 全球傳染病患者病率上升
      • 遺傳疾病發生率上升
    • 限制與挑戰
      • 成本高且需要專用設備
  • PESTLE 分析
  • 核酸擴增檢測市場使用趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第5章 全球核酸擴增檢測市場（依類型）

  • 主要分析結果
  • 簡介
  • PCR 檢測
  • INAAT 偵測
  • LCR 檢測

第6章 全球核酸擴增檢測市場（依應用）

  • 主要分析結果
  • 簡介
  • 傳染病檢測
  • Deep Tensor
  • 腫瘤學檢測
  • 基因和粒線體疾病檢測
  • 其他

第7章 全球核酸擴增檢測市場（依最終用途）

  • 主要分析結果
  • 簡介
  • 醫院
  • 中心實驗室
  • 參考實驗室
  • 其他

第8章 全球核酸擴增檢測市場（依地區）

  • 主要分析結果
  • 簡介
    • 各地區核酸擴增檢驗市場分析（2020-2034）
  • 北美
    • 北美：依類型（2020-2034）
    • 北美：依應用（2020-2034）
    • 北美：依最終用途（2020-2034）
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依類型（2020-2034）
    • 歐洲：依應用（2020-2034）
    • 歐洲：依最終用途（2020-2034）
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 亞太地區：依類型（2020-2034）
    • 亞太地區：依應用（2020-2034）
    • 亞太地區：依最終用途（2020-2034）
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東和非洲
    • 中東和非洲：依類型（2020-2034）
    • 中東和非洲：依應用（2020-2034）
    • 中東和非洲：依最終用途（2020-2034）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲地區
  • 拉丁美洲
    • 拉丁美洲：依類型（2020-2034）
    • 拉丁美洲：依應用（2020-2034）
    • 拉丁美洲：依最終用途（2020-2034）
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家

第9章 競爭格局

  • 業務擴張/收購分析
    • 業務擴張
    • 企業收購
  • 合作/協作/協議/公開

第10章 公司簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company（BD）
  • bioMerieux S.A.
  • Danaher Corporation（Cepheid）
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: PM5711

The global nucleic acid amplification testing market size is expected to reach USD 28.86 billion by 2034, according to a new study by Polaris Market Research. The report "Nucleic Acid Amplification Testing Market Size, Share, & Industry Analysis Report: By Type (PCR Tests, INAAT Tests, and LCR Tests), By Application, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Nucleic acid amplification testing, or NAAT, constitutes a powerful suite of molecular techniques designed to pinpoint specific genetic material, encompassing both DNA and RNA, within a biological specimen. The fundamental principle of these tests lies in their capacity to amplify even trace amounts of target nucleic acids to detectable levels. This amplification is essential for achieving the high sensitivity required for early and accurate diagnosis, particularly when dealing with pathogens present in low concentrations or identifying subtle genetic variations that might otherwise go unnoticed. The precision and sensitivity offered by NAAT have established it as a cornerstone in modern diagnostics, playing a pivotal role in clinical decision-making across a spectrum of medical disciplines.

The persistent threat of infectious diseases, including the emergence of novel pathogens and the resurgence of existing ones, necessitates the widespread adoption of sensitive diagnostic tools such as NAAT for effective disease management and containment. Furthermore, the increasing prevalence of genetic disorders and the expanding application of molecular diagnostics in oncology are significant drivers for the market demand trends of NAAT. Ongoing advancements in molecular technologies, leading to the development of more rapid, user-friendly, and cost-effective NAAT platforms, are also broadening their applicability and accessibility, further contributing to the development of these crucial diagnostic assays.

Nucleic Acid Amplification Testing Market Report Highlights:

By type, the polymerase chain reaction (PCR) tests segment held the largest share globally in 2024 due to their high specificity, sensitivity, and broad applicability across various diagnostic areas. Isothermal nucleic acid amplification technology (INAAT) tests are anticipated to exhibit the highest growth rate during the forecast period, driven by the increasing demand for rapid and point-of-care testing solutions.

By application, the infectious disease testing segment constituted the largest application segment in 2024, fueled by the widespread use of NAAT for diagnosing and monitoring a wide array of infectious agents. Oncology testing is expected to be the fastest-growing application segment, driven by the increasing adoption of molecular diagnostics in cancer management and personalized medicine approaches.

By end use, the central and reference laboratories segment accounted for the largest share of the nucleic acid amplification testing market in 2023, attributed to the high volume of tests processed in these facilities and their role as key hubs for specialized testing. The hospitals segment is projected to demonstrate the highest growth rate, driven by the increasing integration of advanced molecular diagnostics within hospital settings for rapid and improved patient care.

By region, North America held the largest share of the market in 2024. The Asia Pacific nucleic acid amplification testing market is projected to record the highest growth rate during the forecast period.

A few of the major players actively operating in the market are F. Hoffmann-La Roche AG; Abbott Laboratories; Thermo Fisher Scientific Inc.; QIAGEN N.V.; bioMerieux S.A.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; Danaher Corporation (Cepheid); Hologic, Inc.; Agilent Technologies, Inc.; and Illumina, Inc.

Polaris Market Research has segmented the nucleic acid amplification testing market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD Billion, 2020-2034)

PCR Tests

INAAT Tests

LCR Tests

By Application Outlook (Revenue - USD Billion, 2020-2034)

Infectious Disease Testing

Oncology Testing

Genetic & Mitochondrial Disease Testing

Others

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Hospitals

Central

Reference Laboratories

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Nucleic Acid Amplification Testing Market Insights

  • 4.1. Nucleic Acid Amplification Testing Market - Market Snapshot
  • 4.2. Nucleic Acid Amplification Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global Prevalence of Infectious Diseases
      • 4.2.1.2. Increasing Incidence of Genetic Disorders
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and need for specialized equipment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Nucleic Acid Amplification Testing Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Nucleic Acid Amplification Testing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. PCR Tests
    • 5.3.1. Global Nucleic Acid Amplification Testing Market, by PCR Tests, by Region, 2020-2034 (USD Billion)
  • 5.4. INAAT Tests
    • 5.4.1. Global Nucleic Acid Amplification Testing Market, by INAAT Tests, by Region, 2020-2034 (USD Billion)
  • 5.5. LCR Tests
    • 5.5.1. Global Nucleic Acid Amplification Testing Market, by LCR Tests, by Region, 2020-2034 (USD Billion)

6. Global Nucleic Acid Amplification Testing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Infectious Disease Testing
    • 6.3.1. Global Nucleic Acid Amplification Testing Market, by Infectious Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Tensor
    • 6.4.1. Global Nucleic Acid Amplification Testing Market, by Deep Tensor, by Region, 2020-2034 (USD Billion)
  • 6.5. Oncology Testing
    • 6.5.1. Global Nucleic Acid Amplification Testing Market, by Oncology Testing, by Region, 2020-2034 (USD Billion)
  • 6.6. Genetic & Mitochondrial Disease Testing
    • 6.6.1. Global Nucleic Acid Amplification Testing Market, by Genetic & Mitochondrial Disease Testing, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Nucleic Acid Amplification Testing Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Nucleic Acid Amplification Testing Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Central
    • 7.4.1. Global Nucleic Acid Amplification Testing Market, by Central, by Region, 2020-2034 (USD Billion)
  • 7.5. Reference Laboratories
    • 7.5.1. Global Nucleic Acid Amplification Testing Market, by Reference Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Nucleic Acid Amplification Testing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Nucleic Acid Amplification Testing Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Nucleic Acid Amplification Testing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Nucleic Acid Amplification Testing Market - North America
    • 8.3.1. North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Nucleic Acid Amplification Testing Market - U.S.
      • 8.3.4.1. U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Nucleic Acid Amplification Testing Market - Canada
      • 8.3.5.1. Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Nucleic Acid Amplification Testing Market - Europe
    • 8.4.1. Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Nucleic Acid Amplification Testing Market - UK
      • 8.4.4.1. UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Nucleic Acid Amplification Testing Market - France
      • 8.4.5.1. France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Nucleic Acid Amplification Testing Market - Germany
      • 8.4.6.1. Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Nucleic Acid Amplification Testing Market - Italy
      • 8.4.7.1. Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Nucleic Acid Amplification Testing Market - Spain
      • 8.4.8.1. Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Nucleic Acid Amplification Testing Market - Netherlands
      • 8.4.9.1. Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Nucleic Acid Amplification Testing Market - Russia
      • 8.4.10.1. Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Nucleic Acid Amplification Testing Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Nucleic Acid Amplification Testing Market - Asia Pacific
    • 8.5.1. Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Nucleic Acid Amplification Testing Market - China
      • 8.5.4.1. China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Nucleic Acid Amplification Testing Market - India
      • 8.5.5.1. India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Nucleic Acid Amplification Testing Market - Malaysia
      • 8.5.6.1. Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Nucleic Acid Amplification Testing Market - Japan
      • 8.5.7.1. Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Nucleic Acid Amplification Testing Market - Indonesia
      • 8.5.8.1. Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Nucleic Acid Amplification Testing Market - South Korea
      • 8.5.9.1. South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Nucleic Acid Amplification Testing Market - Australia
      • 8.5.10.1. Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Nucleic Acid Amplification Testing Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Nucleic Acid Amplification Testing Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Nucleic Acid Amplification Testing Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Nucleic Acid Amplification Testing Market - UAE
      • 8.6.5.1. UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Nucleic Acid Amplification Testing Market - Israel
      • 8.6.6.1. Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Nucleic Acid Amplification Testing Market - South Africa
      • 8.6.7.1. South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Nucleic Acid Amplification Testing Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Nucleic Acid Amplification Testing Market - Latin America
    • 8.7.1. Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Nucleic Acid Amplification Testing Market - Mexico
      • 8.7.4.1. Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Nucleic Acid Amplification Testing Market - Brazil
      • 8.7.5.1. Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Nucleic Acid Amplification Testing Market - Argentina
      • 8.7.6.1. Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Nucleic Acid Amplification Testing Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Agilent Technologies, Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Becton, Dickinson and Company (BD)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. bioMerieux S.A.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher Corporation (Cepheid)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. F. Hoffmann-La Roche AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hologic, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Illumina, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. QIAGEN N.V.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Siemens Healthineers AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Nucleic Acid Amplification Testing Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Nucleic Acid Amplification Testing Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Nucleic Acid Amplification Testing Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Nucleic Acid Amplification Testing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Nucleic Acid Amplification Testing Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Nucleic Acid Amplification Testing Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Nucleic Acid Amplification Testing Market, by End Use, 2024 & 2034 (USD Billion)